1. Successful use of ECMO and lipid emulsion for massive bupropion overdose: a case report
- Author
-
Michael E. O’Brien, Michael Chary, Philicia Moonsamy, Michele M. Burns, Andrew Tom, and Gaston Cudemus
- Subjects
Bupropion ,ECMO ,lipid emulsion ,pharmacokinetics ,case report ,Toxicology. Poisons ,RA1190-1270 - Abstract
AbstractIntroduction Bupropion overdose can produce seizures, arrhythmias, and shock. The toxicokinetics of massive bupropion ingestions are not well characterized.Case report A 22-year-old female ingested an estimated 40.5 g (644 mg/kg) of extended release bupropion. Subsequently she experienced seizures, required intubation, developed torsades des pointes that progressed to cardiac arrest, and required cannulation with venous-arterial extracorporeal membrane oxygenation (VA-ECMO). Intravenous lipid emulsion was administered without adversely affecting the ECMO circuit. The patient was successfully decannulated after 84 h of ECMO support and discharged neurologically intact. Serial bupropion and hydroxybupropion serum concentrations were drawn every 6-12 h starting on hospital day one and continuing for seven days, for a total of 22 serum concentrations each.Discussion The patient’s first bupropion and hydroxybupropion serum concentrations were 4000 ng/mL and 5300 ng/mL, respectively. Clearance of bupropion followed first order kinetics (t ½ = 20.6 h) while hydroxybupropion had zero order kinetics (t ½ = 118.5 h).Conclusion This bupropion overdose was treated with VA-ECMO with 20% lipid emulsion therapy, without complications. In this patient, the toxicokinetics of bupropion were first-order.
- Published
- 2021
- Full Text
- View/download PDF